MedWellAI MWAI

OTC MWAI
$0.16 -0.13 (-44.83%)
At close: Nov 9, 2026 · 4:00 PM EST

MedWellAI (MWAI) stock price is $0.16, down 44.83% on the day, as of Nov 9, 2026. It has a market cap of $933.70K, and is classified in the Drug Distribution industry (Healthcare sector).

Key Stats
Market Cap933,700.38
P/E-0.59
FCF (Yr)-315,088.00
ROA (Yr)-336.79
EV to EBIT-0.29
Net Income (Yr)-1.59 Mn
Enterprise Value356,726.38
Add ratio to table…

About

MedWellAI, Inc. is a diversified holdings company that develops, acquires, operates, and invests in unique and profitable businesses, with a primary focus on AI driven healthcare and wellness solutions. The company conducts its operations through its subsidiary MedWell USA, which runs a B2B ecommerce platform for distributing pharmaceutical products. In addition to its current healthcare focus, MedWellAI previously engaged in digital asset mining activities and held an…

Read more ↓
Sector: Healthcare Sector rationale The company's dominant business line is MedWell USA, which operates a B2B ecommerce platform for distributing pharmaceutical products, specifically GLP medications, to healthcare providers like wellness clinics and med spas. This activity falls directly under the 'Drug Distribution' industry within the Healthcare sector. While the platform uses AI, the revenue is generated from the sale and distribution of medical products, and previous activities in digital asset mining and consumer sales have been discontinued. Industry: Drug Distribution Drug Distribution Primary MedWellAI operates through its subsidiary MedWell USA, which runs a B2B ecommerce platform for distributing pharmaceutical products, specifically GLP medications. Its primary revenue is generated from product sales to healthcare providers such as wellness clinics and med spas. Classified using BQ-MICS CIK: 0001520118

Subsegments Breakdown of Revenue (2025)

History
Peer percentiles

How MedWellAI ranks

Ranked against the 27 companies in Healthcare Payers and Distributors58 metrics · as of Nov 6, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/ENegative earnings −0.60xMedian 25.1x 8th
  • P/FCFNegative free cash flow −3.12xMedian 16.4x 8th
  • P/Operating cash flowNegative operating cash flow −3.20xMedian 13.6x 4th
  • P/S 10.2xMedian 0.40x 1st
  • P/BNegative shareholder equity −0.12xMedian 2.64x Not meaningful —
  • P/Tangible bookNegative tangible equity −0.12xMedian 3.26x Not meaningful —
  • EV/EBITDANegative EBITDA −6.50xMedian 14.2x 14th
  • EV/EBITNegative EBIT −6.39xMedian 18.9x 21st
  • EV/Revenue 81.9xMedian 0.44x 1st
  • EV/FCFNegative free cash flow −25.1xMedian 17.8x 22nd
  • EV/Operating cash flowNegative operating cash flow −25.7xMedian 15.3x 22nd
  • PEG (3Y EPS CAGR)Negative earnings −0.01Median 1.51 Not meaningful —
Peer group

Peer Comparison

Companies in the Drug Distribution
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 UNH Unitedhealth Group Inc 356.05 Bn22.420.7974.33 Bn
2 MCK Mckesson Corp 123.13 Bn26.200.299.21 Bn
3 CVS CVS HEALTH Corp 109.04 Bn9.880.2660.68 Bn
4 ELV Elevance Health, Inc. 90.56 Bn17.620.4530.76 Bn
5 CI Cigna Group 77.41 Bn12.920.2731.14 Bn
6 COR Cencora, Inc. 66.63 Bn25.390.2011.72 Bn
7 CAH Cardinal Health Inc 63.51 Bn34.930.258.82 Bn
8 MWAI MedWellAI, Inc. 0.00 Bn-0.599.680.01 Bn